The Finance and Accounting Team at Edgewise Therapeutics plays a crucial role in managing the company's financial health, ensuring accurate financial reporting, budgeting, and compliance. Led by the Chief Financial Officer, the team collaborates to provide strategic insights that support the advancement of therapeutic developments and the efficient allocation of resources, particularly during critical funding phases like the recent Series B financing. Their expertise in financial analysis and management helps drive the company's growth trajectory within the biotechnology sector.
View all